A prominent example of pro-oncogenic PTP in neuroblastoma is PTPN11, whose gene is mutated with relative frequency in high-risk neuroblastoma tumors and whose inhibition by both allosteric and catalytic inhibitors is under intense scrutiny in neuroblastoma experimental models. Here, PTPN11 is linked to neuroblastoma.